John M. Climaco
Chief Executive Officer at CNS Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: CNS Pharmaceuticals Inc., 3 years.
CNS Pharmaceuticals Inc.
Director · Chief Executive Officer
Moleculin Biotech Inc.
Director
Chief executive roles
CNS Pharmaceuticals Inc.
· Chief Executive Officer
Until January 2026
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 1, 2024 | CNS Pharmaceuticals Inc. | Open-market purchase | +166,666 | $0.30 | $50,000 |
| Aug 16, 2023 | CNS Pharmaceuticals Inc. | Open-market purchase | +2,750 | $1.80 | $4,950 |
| Apr 28, 2023 | CNS Pharmaceuticals Inc. | Option exercise | +1,250 | — | — |
| Apr 12, 2023 | CNS Pharmaceuticals Inc. | Open-market purchase | +15,000 | $0.69 | $10,350 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.